Hypercortisolemia inhibits yohimbine-induced release of norepinephrine in the posterolateral hypothalamus of conscious rats

Karel Pacak, Ines Armando, S. Komoly, Koki Fukuhara, Virginia K. Weise, Courtney Holmes, Irwin J. Kopin, David S. Goldstein

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Chronic hypercortisolemia attenuates yohimbine (YOH)-induced increments in plasma levels of the sympathetic neurotransmitter norepinephrine (NE). The present study used in vivo microdialysis to study the effects of hypercortisolemia on YOH-induced release of NE in the brain. Cortisol (25 mg/kg·day) or saline was infused sc into rats for 7 days via an osmotic minipump. Microdialysate and plasma concentrations of NE and its metabolites dihydroxyphenylglycol and methoxyhydroxyphenylglycol were measured before and after YOH (1 mg/ kg, iv) administration in conscious animals, with microdialysate and plasma collections beginning 20-24 h after probe implantation. Chronic cortisol treatment resulted in attenuated NE, dihydroxyphenylglycol, and methoxyhydroxyphenylglycol responses in both microdialysate and plasma. The results indicate that YOH increases central neural as well as peripheral release, reuptake, turnover, and metabolism of NE and that hypercortisolemia suppresses these responses.

Original languageEnglish
Pages (from-to)1369-1376
Number of pages8
JournalEndocrinology
Volume131
Issue number3
Publication statusPublished - Sep 1992

Fingerprint

Yohimbine
Hypothalamus
Norepinephrine
Methoxyhydroxyphenylglycol
Hydrocortisone
Microdialysis
Neurotransmitter Agents
Brain

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Pacak, K., Armando, I., Komoly, S., Fukuhara, K., Weise, V. K., Holmes, C., ... Goldstein, D. S. (1992). Hypercortisolemia inhibits yohimbine-induced release of norepinephrine in the posterolateral hypothalamus of conscious rats. Endocrinology, 131(3), 1369-1376.

Hypercortisolemia inhibits yohimbine-induced release of norepinephrine in the posterolateral hypothalamus of conscious rats. / Pacak, Karel; Armando, Ines; Komoly, S.; Fukuhara, Koki; Weise, Virginia K.; Holmes, Courtney; Kopin, Irwin J.; Goldstein, David S.

In: Endocrinology, Vol. 131, No. 3, 09.1992, p. 1369-1376.

Research output: Contribution to journalArticle

Pacak, K, Armando, I, Komoly, S, Fukuhara, K, Weise, VK, Holmes, C, Kopin, IJ & Goldstein, DS 1992, 'Hypercortisolemia inhibits yohimbine-induced release of norepinephrine in the posterolateral hypothalamus of conscious rats', Endocrinology, vol. 131, no. 3, pp. 1369-1376.
Pacak, Karel ; Armando, Ines ; Komoly, S. ; Fukuhara, Koki ; Weise, Virginia K. ; Holmes, Courtney ; Kopin, Irwin J. ; Goldstein, David S. / Hypercortisolemia inhibits yohimbine-induced release of norepinephrine in the posterolateral hypothalamus of conscious rats. In: Endocrinology. 1992 ; Vol. 131, No. 3. pp. 1369-1376.
@article{7d73b14dfda34e31b0fb8d5aa891885c,
title = "Hypercortisolemia inhibits yohimbine-induced release of norepinephrine in the posterolateral hypothalamus of conscious rats",
abstract = "Chronic hypercortisolemia attenuates yohimbine (YOH)-induced increments in plasma levels of the sympathetic neurotransmitter norepinephrine (NE). The present study used in vivo microdialysis to study the effects of hypercortisolemia on YOH-induced release of NE in the brain. Cortisol (25 mg/kg·day) or saline was infused sc into rats for 7 days via an osmotic minipump. Microdialysate and plasma concentrations of NE and its metabolites dihydroxyphenylglycol and methoxyhydroxyphenylglycol were measured before and after YOH (1 mg/ kg, iv) administration in conscious animals, with microdialysate and plasma collections beginning 20-24 h after probe implantation. Chronic cortisol treatment resulted in attenuated NE, dihydroxyphenylglycol, and methoxyhydroxyphenylglycol responses in both microdialysate and plasma. The results indicate that YOH increases central neural as well as peripheral release, reuptake, turnover, and metabolism of NE and that hypercortisolemia suppresses these responses.",
author = "Karel Pacak and Ines Armando and S. Komoly and Koki Fukuhara and Weise, {Virginia K.} and Courtney Holmes and Kopin, {Irwin J.} and Goldstein, {David S.}",
year = "1992",
month = "9",
language = "English",
volume = "131",
pages = "1369--1376",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Hypercortisolemia inhibits yohimbine-induced release of norepinephrine in the posterolateral hypothalamus of conscious rats

AU - Pacak, Karel

AU - Armando, Ines

AU - Komoly, S.

AU - Fukuhara, Koki

AU - Weise, Virginia K.

AU - Holmes, Courtney

AU - Kopin, Irwin J.

AU - Goldstein, David S.

PY - 1992/9

Y1 - 1992/9

N2 - Chronic hypercortisolemia attenuates yohimbine (YOH)-induced increments in plasma levels of the sympathetic neurotransmitter norepinephrine (NE). The present study used in vivo microdialysis to study the effects of hypercortisolemia on YOH-induced release of NE in the brain. Cortisol (25 mg/kg·day) or saline was infused sc into rats for 7 days via an osmotic minipump. Microdialysate and plasma concentrations of NE and its metabolites dihydroxyphenylglycol and methoxyhydroxyphenylglycol were measured before and after YOH (1 mg/ kg, iv) administration in conscious animals, with microdialysate and plasma collections beginning 20-24 h after probe implantation. Chronic cortisol treatment resulted in attenuated NE, dihydroxyphenylglycol, and methoxyhydroxyphenylglycol responses in both microdialysate and plasma. The results indicate that YOH increases central neural as well as peripheral release, reuptake, turnover, and metabolism of NE and that hypercortisolemia suppresses these responses.

AB - Chronic hypercortisolemia attenuates yohimbine (YOH)-induced increments in plasma levels of the sympathetic neurotransmitter norepinephrine (NE). The present study used in vivo microdialysis to study the effects of hypercortisolemia on YOH-induced release of NE in the brain. Cortisol (25 mg/kg·day) or saline was infused sc into rats for 7 days via an osmotic minipump. Microdialysate and plasma concentrations of NE and its metabolites dihydroxyphenylglycol and methoxyhydroxyphenylglycol were measured before and after YOH (1 mg/ kg, iv) administration in conscious animals, with microdialysate and plasma collections beginning 20-24 h after probe implantation. Chronic cortisol treatment resulted in attenuated NE, dihydroxyphenylglycol, and methoxyhydroxyphenylglycol responses in both microdialysate and plasma. The results indicate that YOH increases central neural as well as peripheral release, reuptake, turnover, and metabolism of NE and that hypercortisolemia suppresses these responses.

UR - http://www.scopus.com/inward/record.url?scp=0026802399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026802399&partnerID=8YFLogxK

M3 - Article

VL - 131

SP - 1369

EP - 1376

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 3

ER -